THE EFFECT OF RE-RESECTION IN EXTREMITY SOFT TISSUE SARCOMA
CLASSIFICATION OF POSITIVE MARGINS AFTER RESECTION OF EXTREMITY SOFT TISSUE SARCOMA PREDICTS THE RISK OF LOCAL RECURRENCE
COMBINED MODALITY MANAGEMENT OF RETROPERITONEAL SARCOMAS: PHASE I TRIAL OF PREOPERATIVE DOXORUBICIN-BASED CONCURRENT CHEMORADIATION, SURGICAL RESECTION, AND INTRAOPERATIVE ELECTRON-BEAM RADIATION THERAPY (IORT)
COMPLETE RESECTION AND INTRA-OPERATIVE RADIATION THERAPY IMPROVE OUTCOME OF RETROPERITONEAL SARCOMAS
RADIATION MORBIDITY TWO YEARS POST TREATMENT: RESULTS FROM RANDOMIZED TRIAL OF PRE-VERSUS POSTOPERTATIVE RADIOTHERAPY
REAL-TIME READIOTHERAPY REVIEW OF A RANDOMIZED TRIAL OF PRE- AND POST-OPERATIVE RADIOTHERAPY OF LOCALIZED SOT-TISSUE SARCOMA OF THE EXTREMITY
DIFFERENTIAL EXPRESSION OF EZRIN IN A HIGH AND LOW METASTATIC OSTEOSARCOMA MODEL
MOLECULAR CLONING OF PUTATIVE ONCOGENE AND ANTIONCOGENE INVOLVED IN THE DEVELOPMENT OF OSTEOSARCOMA
CLINICO-PATHOLOGICAL AND BIOLOGICAL ANALYSES OF THE CHOP-RELATED FUSION GENES IN MYXOID LIPOSARCOMAS
CYTOKINE LEVELS IN SERUM OF THE PATIENTS WITH SOFT TISSUE SARCOMAS AND THEIR RELATIONSHIP TO ALTERATIONS OF ROUTINE BLOOD TESTS
WILD-TYPE P53 SENSITIZES SOFT TISSUE SARCOMA CELLS TO DOXORUBICIN BY DOWNREGULATION OF MDR1 EXPRESSION
REGULATION OF OSTEOSARCOMA (OS) METASTASIS BY IGF-I RECEPTOR SIGNALING: A NOVEL THERAPEUTIC TARGET
RESULTS OF TWO CONSECUTIVE PHASE II STUDIES AND INTERIM ANALYSIS OF A PHASE III INTERGROUP STUDY OF NEOADJUVANT TREATMENT INCLUDING REGIONAL HYPERTHERMIA (RHT) IN HIGH RISK SOFT TISSUE SARCOMA (HR-STS) PATIENTS
EXPRESSION OF THE TRAIL RECEPTOR DR4 IN HUMAN SOFT TISSUE SARCOMAS
DOMINANT NEGATIVE IkBa POTENTIATES IN ANTI-TUMOR ACTIVITY OF DOXORUBICIN IN A RAT HIND LIMB ISOLATED PERFUSION MODEL
A PILOT STUDY OF SHORT COURSE, INTENSIVE, MULTIAGENT CHEMOTHERAPY FOR POOR RISK OSTEOSARCOMA
A PHASE I TRIAL OF INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY FOR THE TREATMENT OF SARCOMATOSIS
CD99 ENGAGEMENT: AN EFFECTIVE THERAPEUTIC STRATEGY FOR EWING TUMORS
INTRODUCTION OF CHEMORESISTANCE TO DOXORUBICIN IN CELLS CARRYING A P53 GERMLINE MUTATION DETECTED IN A LI-FRAUMENI FAMILY
STUDY OF AGE AS MAJOR PRONOSTIC FACTOR IN LOCALIZED EWING’S SARCOMA
MONITORING THE EFFECT OF ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMA WITH DYNAMIC CONTRAST-ENHANCED MR IMAGING
UPREGULATION OF PTHrP AND BCL-2 EXPRESSION CHARACTERIZES EARLY MALIGNANT TRANSFORMATION OF OSTEOCHONDROMA TOWARDS PERIPHERAL CHONDROSARCOMA AND IS A LATE EVENT IN CENTRAL CHONDROSARCOMA
DOES THE HISTOLOGIC SUBTYPE OF HIGH-GRADE CENTRAL OSTEOSARCOMA INFLUENCE THE RESPONSE TO TREATMENT WITH CHEMOTHERAPY AND DOES IT AFFECT OVERALL SURVIVAL? A STUDY BASED ON THE MATERIAL OF TWO CONSECUTIVE TRIALS OF EUROPEAN OSTEOSARCOMA INTERGROUP (EOI) CONSISTING OF 50 PATIENTS
ROUND-CELL AND MYXOID LIPOSARCOMA OF THE EXTREMITIES. A CLINICOPATHOLOGIC STUDY OF 102 CASES
